Reliable information can be obtained on the progression of dementias by measuring specific proteins in the blood and cerebrospinal fluid. A test of this kind is especially significant to the development of new therapies, as reported in the journal Neuron by scientists from the University of Basel and University Hospital Basel, along with international colleagues.
from Dementia Big http://ift.tt/1thgsi9 via alcoholic dementia
http://ift.tt/1YjWu2f
No comments:
Post a Comment